RIG-I Agonistic-TLR-Antagonistic mRNA Platform to Enhance the Safety & Efficacy of mRNA Therapeutics
- Demonstrating superior Chikungunya mRNA vaccine safety and efficacy by RIG-I agonism and TLR antagonism
- How does each component of Celestial’s novel mRNA platform work to make mRNA therapeutics better?
- Showcasing a novel COVID mucosal mRNA vaccine